• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GENZYME CORPORATION(RIDGEFIELD) SYNVISC MOZ

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GENZYME CORPORATION(RIDGEFIELD) SYNVISC MOZ Back to Search Results
Lot Number 9RSP014A
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Fatigue (1849); Headache (1880); Joint Swelling (2356); No Code Available (3191)
Event Date 07/01/2020
Event Type  Injury  
Event Description
Could barely walk [walking difficulty], sharp pain in her mid-calf area [calf pain], quiet exhausted [exhaustion], slight headache [headache], swelling in her ankle/had a lot of swelling in her knee [ankle swelling]. Case narrative: this case is linked to cases (b)(4) (multiple device; same patient). Initial information received on 27-jul-2020 regarding an unsolicited valid serious case received from united states via patient. This case involves a (b)(6) years old female patient who started treatment with hylan g-f 20, sodium hyaluronate (synvisc) and experienced sharp pain in her mid-calf area, could barely walk, quiet exhausted, slight headache and swelling in her ankle/had a lot of swelling in her knee. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Patient had a history of getting hylan g-f 20, sodium hyaluronate (synvisc) injections and had no issues afterwards (about 2. 5 years ago). On (b)(6) 2020, the patient started receiving hylan g-f 20, sodium hyaluronate injection weekly(dose, route and batch number unknown) for unknown indication. It was reported that before second injection, there was no fluid to drain and on (b)(6) 2020, patient received second hylan g-f 20, sodium hyaluronate injection. On an unknown date in (b)(6) 2020, after few days of receiving this second injection, patient had a slight headache, sharp pain in her mid-calf area, swelling in her ankle and the same symptoms which she had after receiving first injection that included; could barely walk (disability), she had a lot of swelling in her knee and she was quiet exhausted. It was reported, she had to use a walker to get around. Patient received third injection on (b)(6) 2020. On an unknown date in (b)(6) 2020, patient was just now able to walk and it had been 5 days since receiving the last (third) shot. Action taken: no action taken for all events. Corrective treatment: has to use a walker to get around for could barely walk. The patient outcome is reported as recovered for could barely walk; unknown for rest events.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand NameSYNVISC
Type of DeviceMOZ
Manufacturer (Section D)
GENZYME CORPORATION(RIDGEFIELD)
1125 pleasantview terrace
ridgefield 07657
Manufacturer (Section G)
GENZYME CORPORATION(RIDGEFIELD)
1125 pleasantview terrace
ridgefield 07657
Manufacturer Contact
heather schiappacasse
55 corporate drive, ms 55b-220
a
bridgewater 08807
MDR Report Key10349266
MDR Text Key202039055
Report Number2246315-2020-00085
Device Sequence Number1
Product Code MOZ
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,health professional
Type of Report Initial,Followup,Followup,Followup,Followup
Report Date 01/29/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/31/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator
Device Lot Number9RSP014A
Was Device Available for Evaluation? No
Was the Report Sent to FDA?
Event Location No Information
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial

Patient Treatment Data
Date Received: 07/31/2020 Patient Sequence Number: 1
-
-